Therefore, it is not surprising that PLK1 expression is increased in various human malignant tumors, such as breast cancer, colorectal cancer, and melanoma, and PLK1 upregulation is associated with the poor prognosis of cancer patients (Takai et al., 2005) (Gutteridge et al., 2016). This evidence concerns the gene PLK1 and breast cancer.